Suppression of cancers

Details for Australian Patent Application No. 2009259034 (hide)

Owner Syntaxin Limited

Inventors Madec, Frederic; Foster, Keith; Marks, Philip; Lecane, Phil

Agent Freehills

Pub. Number AU-A-2009259034

PCT Pub. Number WO2009/150470

Priority 0820965.2 17.11.08 GB; 0810782.3 12.06.08 GB

Filing date 11 June 2009

Wipo publication date 17 December 2009

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2009/150470 Priority application(s): WO2009/150470

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009259038-Dihydrotetrabenanzine for the treatment of anxiety

2009259033-Suppression of neuroendocrine diseases